SING GEORGE L 1225471 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-04 | 2024-01-02 | 2024-01-02 | 4 | Sing George L | DIRECTOR | acq | 135.0 | 0.51 | 0.01 | 0.0 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code A | 26349.0 | 107.13 (REGN) |
| 2024-01-04 | 2024-01-02 | 4 | Sing George L | DIRECTOR | holding | 750.0 | 0 | 0.07 | 0.0 | By Spouse | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2024-01-04 | 2024-01-02 | 4 | Sing George L | DIRECTOR | holding | 400.0 | 0 | 0.04 | 0.0 | By Spouse/Cust Son | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2024-01-04 | 2024-01-02 | 4 | Sing George L | DIRECTOR | holding | 1000.0 | 0 | 0.09 | 0.0 | By Trust For Son | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.13 (REGN) | ||
| 2024-02-12 | 2024-02-08 | 2024-02-08 to 2024-02-09 | 4 | Sing George L | DIRECTOR | acq | 1000.0 | 3.72 | 0.09 | 413.33 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code M | 26849.0
|
107.94 (REGN) |
| 2024-02-12 | 2024-02-08 | 2024-02-08 to 2024-02-09 | 4 | Sing George L | DIRECTOR | dsp | 1000.0 | 3.66 | 0.09 | 950.0 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 26349.0
|
107.94 (REGN) |
| 2024-02-12 | 2024-02-08 | 4 | Sing George L | DIRECTOR | holding | 400.0 | 0 | 0.04 | 0.0 | By Spouse/Cust Son | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-02-12 | 2024-02-08 | 4 | Sing George L | DIRECTOR | holding | 750.0 | 0 | 0.07 | 0.0 | By Spouse | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-02-12 | 2024-02-08 | 4 | Sing George L | DIRECTOR | holding | 1000.0 | 0 | 0.09 | 0.0 | By Trust For Son | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-02-26 | 2024-02-22 | 4 | Sing George L | DIRECTOR | holding | 1000.0 | 0 | 0.09 | 0.0 | By Trust For Son | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-02-26 | 2024-02-22 | 4 | Sing George L | DIRECTOR | holding | 400.0 | 0 | 0.04 | 0.0 | By Spouse/Cust Son | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-02-26 | 2024-02-22 | 4 | Sing George L | DIRECTOR | holding | 750.0 | 0 | 0.07 | 0.0 | By Spouse | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-02-26 | 2024-02-22 | 2024-02-22 to 2024-02-23 | 4 | Sing George L | DIRECTOR | dsp | 3500.0 | 11.73 | 0.32 | 967.86 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 26349.0
|
107.94 (REGN) |
| 2024-02-26 | 2024-02-22 | 2024-02-22 to 2024-02-23 | 4 | Sing George L | DIRECTOR | acq | 3500.0 | 13.04 | 0.32 | 413.33 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code M | 26849.0
|
107.94 (REGN) |
| 2024-02-28 | 2024-02-26 | 4 | Sing George L | DIRECTOR | holding | 400.0 | 0 | 0.04 | 0.0 | By Spouse/Cust Son | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-02-28 | 2024-02-26 | 4 | Sing George L | DIRECTOR | holding | 1000.0 | 0 | 0.09 | 0.0 | By Trust For Son | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-02-28 | 2024-02-26 | 4 | Sing George L | DIRECTOR | holding | 750.0 | 0 | 0.07 | 0.0 | By Spouse | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 107.94 (REGN) | ||
| 2024-02-28 | 2024-02-26 | 2024-02-26 | 4 | Sing George L | DIRECTOR | dsp | 1000.0 | 3.66 | 0.09 | 992.5 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code S | 26349.0
|
107.94 (REGN) |
| 2024-02-28 | 2024-02-26 | 2024-02-26 | 4 | Sing George L | DIRECTOR | acq | 1000.0 | 3.72 | 0.09 | 413.33 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code M | 26849.0
|
107.94 (REGN) |
| 2024-05-06 | 2024-05-03 | 2024-05-03 | 4 | Sing George L | DIRECTOR | dsp | 877.0 | 3.09 | 0.08 | 942.53 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code F | 27472.0 | 108.37 (REGN) |
| 2024-05-06 | 2024-05-03 | 2024-05-03 | 4 | Sing George L | DIRECTOR | acq | 2000.0 | 7.05 | 0.18 | 413.33 | Direct | Common Stock | REGENERON PHARMACEUTICALS, INC. | code M | 28349.0 | 108.37 (REGN) |
| 2024-05-06 | 2024-05-03 | 4 | Sing George L | DIRECTOR | holding | 400.0 | 0 | 0.04 | 0.0 | By Spouse/Cust Son | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 108.37 (REGN) | ||
| 2024-05-06 | 2024-05-03 | 4 | Sing George L | DIRECTOR | holding | 750.0 | 0 | 0.07 | 0.0 | By Spouse | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 108.37 (REGN) | ||
| 2024-05-06 | 2024-05-03 | 4 | Sing George L | DIRECTOR | holding | 1000.0 | 0 | 0.09 | 0.0 | By Trust For Son | Common Stock | REGENERON PHARMACEUTICALS, INC. | NA | 108.37 (REGN) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-04 | 2024-01-02 | 2024-01-02 | 4 | Sing George L | DIRECTOR | acq | 1607.0 | 100.0 | 0.15 | 888.34 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code A | 1607.0 | 107.13 (REGN) |
| 2024-02-12 | 2024-02-08 | 2024-02-08 to 2024-02-09 | 4 | Sing George L | DIRECTOR | dsp | 1000.0 | 9.23 | 0.09 | 413.33 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code M | 9838.0
|
107.94 (REGN) |
| 2024-02-26 | 2024-02-22 | 2024-02-22 to 2024-02-23 | 4 | Sing George L | DIRECTOR | dsp | 3500.0 | 35.58 | 0.32 | 413.33 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code M | 6338.0
|
107.94 (REGN) |
| 2024-02-28 | 2024-02-26 | 2024-02-26 | 4 | Sing George L | DIRECTOR | dsp | 1000.0 | 15.78 | 0.09 | 413.33 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code M | 5338.0 | 107.94 (REGN) |
| 2024-05-06 | 2024-05-03 | 2024-05-03 | 4 | Sing George L | DIRECTOR | dsp | 2000.0 | 37.47 | 0.18 | 413.33 | Direct | Non Qualified Stock Option (Right To Buy) | REGENERON PHARMACEUTICALS, INC. | code M | 3338.0 | 108.37 (REGN) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)